Publication: Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.
Loading...
Identifiers
Date
2020-06-17
Authors
Montero-Vilchez, Trinidad
Martinez-Lopez, Antonio
Salvador-Rodriguez, Luis
Molina-Leyva, Alejandro
Arias-Santiago, Salvador
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Limited
Abstract
The recent coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe acute respiratory syndrome-associated coronavirus type 2 (SARS-CoV-2) virus, has spread all over the world. As of April 21, 2020, there were 2 478 948 cases of infection, of which 652 046 have resolved, and 170 399 people have died in 185 different countries. The elderly and people with underlying conditions such as cardiovascular disease, obesity, diabetes or cancer are at the highest risk of infection and prone to serious outcomes.
Description
MeSH Terms
COVID-19
Hidradenitis Suppurativa
Humans
SARS-CoV-2
Hidradenitis Suppurativa
Humans
SARS-CoV-2
DeCS Terms
Hidradenitis supurativa
SARS-CoV-2
Humanos
SARS-CoV-2
Humanos
CIE Terms
Keywords
Hidradenitis Suppurativa, Aged, Cardiovascular Diseases, Pandemics, Death, Obesity
Citation
Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e13875.